Corline Biomedical AB's total assets for Q1 2026 were kr115.97M, an increase of 17.65% from the previous quarter. SE:CLBIO total liabilities were kr15.53M for the fiscal quarter, a 222.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.